Papillary Thyroid Carcinoma (PTC)
In a patient with known thyroiditis whose FNA shows malignant cells, the most likely tumor is papillary thyroid carcinoma (PTC), which represents the vast majority of malignant thyroid tumors and is the most common malignancy that can be definitively identified on FNA cytology.
Reasoning Based on Evidence
The key diagnostic consideration here is understanding which thyroid malignancies can be reliably identified on FNA cytology. According to current guidelines, most malignant thyroid tumors can be identified cytologically 1. However, there are important exceptions that help narrow the differential:
Tumors Identifiable on FNA:
- Papillary thyroid carcinoma - readily diagnosed cytologically
- Medullary thyroid carcinoma - can be identified on FNA
- Anaplastic carcinoma - identifiable when present
- Poorly differentiated carcinoma - only when there is obviously increased mitotic activity and/or necrosis 1
Tumors NOT Reliably Identified on FNA:
- Follicular thyroid carcinoma (FTC) - typically classified as indeterminate because diagnosis requires demonstration of capsular or vascular invasion, which cannot be assessed on cytology 1
- NIFTP (non-invasive follicular thyroid neoplasm with papillary-like nuclear features) - also classified as indeterminate 1
Clinical Context: Thyroiditis Connection
The presence of chronic thyroiditis (particularly Hashimoto's thyroiditis) is a well-established risk factor specifically for papillary thyroid carcinoma. This clinical context further supports PTC as the most likely diagnosis when malignant cells are definitively identified on FNA.
Common Pitfall to Avoid
When FNA shows definitively malignant cells (not indeterminate), you can confidently exclude follicular carcinoma from your primary differential, as FTC cannot be diagnosed cytologically and would be reported as indeterminate/suspicious rather than malignant 1.